84 results on '"Oesterling, Joseph E."'
Search Results
2. PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING
3. HAVE COMPLICATION RATES DECREASED AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER?
4. A PROSPECTIVE, RANDOMIZED 1-YEAR CLINICAL TRIAL COMPARING TRANSURETHRAL NEEDLE ABLATION TO TRANSURETHRAL RESECTION OF THE PROSTATE FOR THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
5. A MODEL FOR THE NUMBER OF CORES PER PROSTATE BIOPSY BASED ON PATIENT AGE AND PROSTATE GLAND VOLUME
6. Update on the Appropriate Staging Evaluation for Newly Diagnosed Prostate Cancer
7. A Nationwide Survey of Practicing Urologists: Current Management of Benign Prostatic Hyperplasia and Clinically Localized Prostate Cancer
8. The Relationship Between Prostatic Intraepithelial Neoplasia and Prostate Cancer: Critical Issues
9. The Periurethral Glands do not Significantly Influence the Serum Prostate Specific Antigen Concentration
10. Prediction of Capsular Perforation and Seminal Vesicle Invasion in Prostate Cancer
11. Standard Versus Age-Specific Prostate Specific Antigen Reference Ranges Among Men With Clinically Localized Prostate Cancer: A Pathological Analysis
12. Re: Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristics Curves
13. Natural History of Prostatism: Longitudinal Changes in Voiding Symptoms in Community Dwelling Men
14. The Effect of Finasteride on Prostate Specific Antigen: Review of Available Data
15. Prostate Cancer Clinical Guidelines Panel Summary Report on the Management of Clinically Localized Prostate Cancer
16. Prostatic Intraepithelial Neoplasia is Risk Factor for Adenocarcinoma: Predictive Accuracy in Needle Biopsies
17. Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios
18. Natural History of Prostatism: Relationship Among Symptoms, Prostate Volume and Peak Urinary Flow Rate
19. The Volume of Prostate Cancer in the Biopsy Specimen Cannot Reliably Predict the Quantity of Cancer in the Radical Prostatectomy Specimen on an Individual Basis
20. The Use of Age-Specific Reference Ranges for Serum Prostate Specific Anitgen in Men 60 years Old or Older
21. The Clinical Usefulness of Prostate Specific Antigen: Update 1994
22. Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer
23. Combining Prostate Specific Antigen with Cancer and Gland Volume to Predict More Reliably Pathological Stage: The Influence of Prostate Specific Antigen Cancer Density
24. Re: The Inability of Prostate Specific Antigen Index to Enhance the Predictive Value of Prostate Specific Antigen in the Diagnosis of Prostatic Carcinoma, by M. K. Brawer, E. A. G. Aramburu, G. L. Chen, S. D. Preston and W. J. Ellis, J. Urol., 150: 369-373, 1993
25. Eliminating the Need for Bilateral Pelvic Lymphadenectomy in Select Patients with Prostate Cancer
26. Prostate Specific Antigen Cannot Distinguish Stage T1a (A1) Prostate Cancer from Benign Prostatic Hyperplasia
27. Transdermal Clonidine for Ameliorating Post-Orchiectomy Hot Flashes
28. Measurement of Serum Prostate Specific Antigen Using Imx Prostate Specific Antigen Assay
29. Similar Levels of Urological Symptoms Have Similar Impact on Scottish and American Men—Although Scots Report Less Symptoms
30. Newly Diagnosed Bulbar Urethral Strictures: Etiology and Outcome of Various Treatments
31. Re: Deferred Treatment of Low Grade Stage T3 Prostate Cancer Without Distant Metastases, by J. Adolfsson, J. Urol., 149: 326-329, 1993
32. Preoperative Androgen Deprivation Therapy: Artificial Lowering of Serum Prostate Specific Antigen without Downstaging the Tumor
33. The Effect of Digital Rectal Examination on the Serum Prostate Specific Antigen Concentration: Results of a Randomized Study
34. Idiopathic Myelofibrosis with Myeloid Metaplasia Involving the Renal Pelves, Ureters and Bladder
35. Small Cell Anaplastic Carcinoma of the Prostate: A Clinical, Pathological and Immunohistological Study of 27 Patients
36. Hormonal Treatment at Time of Radical Retropubic Prostatectomy for Stage D1 Prostate Cancer: Results of Long-Term Followup
37. Squamous Cell Carcinoma of the Scrotum: Long-Term Followup of 14 Patients
38. Editorial Comments
39. Splenosis Presenting as a Left Renal Mass Indistinguishable from Renal Cell Carcinoma
40. Transesophageal Echocardiography in Renal Cell Carcinoma: An Accurate Diagnostic Technique for Intracaval Neoplastic Extension
41. Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
42. Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?
43. Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical Parameters
44. Influence of Age and Endocrine Factors on the Volume of Benign Prostatic Hyperplasia
45. Scrotal Surgery: A Reliable Method for the Prevention of Postoperative Hematoma and Edema
46. Improved Hemostasis During Simple Retropubic Prostatectomy
47. Priapism: Simple Method to Prevent Retumescence Following Initial Decompression
48. Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia
49. Conservative Management of a Seminal Vesicle Abscess
50. Aromatase Inhibition in the Dog. I Effect on Serum LH, Serum Testosterone Concentrations, Testicular Secretions and Spermatogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.